Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Lung Diseases, Interstitial (drug therapy) - Lung Diseases, Interstitial (etiology)

Terms

31Lung Diseases, Interstitial (drug therapy)
15Lung Diseases, Interstitial (etiology)
61Hydroxychloroquine (therapeutic use)
10Methylprednisolone (therapeutic use)
26Tomography, X-Ray Computed
28Drug Therapy, Combination
15Prednisone (therapeutic use)
16Lung Diseases, Interstitial (diagnosis)

Associations

Freq.WeightAssociation
90.417Lung Diseases, Interstitial (drug therapy) - Lung Diseases, Interstitial (etiology)
100.405Hydroxychloroquine (therapeutic use) - Methylprednisolone (therapeutic use)
170.391Hydroxychloroquine (therapeutic use) - Lung Diseases, Interstitial (drug therapy)
90.317Lung Diseases, Interstitial (drug therapy) - Tomography, X-Ray Computed
80.390Drug Therapy, Combination - Prednisone (therapeutic use)
130.315Drug Therapy, Combination - Hydroxychloroquine (therapeutic use)
70.314Lung Diseases, Interstitial (diagnosis) - Lung Diseases, Interstitial (drug therapy)
90.298Hydroxychloroquine (therapeutic use) - Prednisone (therapeutic use)
80.264Hydroxychloroquine (therapeutic use) - Lung Diseases, Interstitial (etiology)
100.251Hydroxychloroquine (therapeutic use) - Tomography, X-Ray Computed
70.238Drug Therapy, Combination - Lung Diseases, Interstitial (drug therapy)

Documents par ordre de pertinence
001072 (2014) Mariam Ischander ; Leland L. Fan ; Vanda Farahmand [États-Unis] ; Claire Langston [États-Unis] ; Shahram Yazdani [États-Unis]Desquamative interstitial pneumonia in a child related to cigarette smoke
004013 (????) Y. Uziel [Israël] ; B. Hen ; M. Cordoba ; B. WolachLymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis.
002156 (2002) M L Kingma [Pays-Bas] ; J H J M. Van Krieken ; J J E M. De Nef ; I T Merth[Persistent tachypnea in infants: possibly due to interstitial pneumonitis].
004015 (????) J. Gordon [États-Unis] ; U. Udeh ; K. Doobay ; C. Magro ; H. Wildman ; M. Davids ; J N Mersten ; W-T Huang ; S. Lyman ; M K Crow ; R F SpieraImatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.
004019 (????) Efstathios E. Detorakis [Grèce] ; Eleftherios Magkanas [Grèce] ; Ismini Lasithiotaki [Grèce] ; Prodromos Sidiropoulos [Grèce] ; Dimitrios T. Boumpas [Grèce] ; Nicholas Gourtsoyiannis [Grèce] ; Katerina Antoniou [Grèce] ; Maria Raissaki [Grèce]Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
000E65 (2015) Águeda Prior-Espa Ol [Espagne] ; Melania Martínez-Morillo [Espagne] ; Anne Riveros-Frutos [Espagne] ; Alejandro Olivé [Espagne][Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
001244 (2013) Duygu Emine Ersozlu Bozkirli [Turquie] ; Ilknur Kozanoglu [Turquie] ; Emre Bozkirli [Turquie] ; Eftal Yucel [Turquie]Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis
001513 (2011) Petros Efthimiou ; Manil Kukar ; Alissa Hersh [États-Unis]Rituximab and lupus interstitial lung disease: friend or foe?
002036 (2003) Ahmed S. Samad [États-Unis] ; Carol B. LindsleyTreatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
002C03 (1994) L L Fan [États-Unis]Evaluation and therapy of chronic interstitial pneumonitis in children.
002C98 (1994) A. Avital [Israël] ; S. Godfrey [Israël] ; C. H. Maayan [Israël] ; Y. Diamant [Israël] ; C. Springer [Israël]Chloroquine treatment of interstitial lung disease in children
000C25 (2018) Safi Alqatari [Oman] ; Peter Riddell [Irlande (pays)] ; Sinead Harney [Irlande (pays)] ; Michael Henry [Irlande (pays)] ; Grainne Murphy [Irlande (pays)]MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
000D20 (2017) Saliha Esenboga [Turquie] ; Nagehan Emiralioglu [Turquie] ; Deniz Cagdas [Turquie] ; Baran Erman [Turquie] ; Martin De Boer [Pays-Bas] ; Berna Oguz [Turquie] ; Nural Kiper [Turquie] ; Lhan Tezcan [Turquie]Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.
000E66 (2015) Raquel Català Pérez [Espagne] ; Antoni Az N Masoliver [Espagne] ; Salvador Hernández Flix [Espagne][Interstitial lung disease induced by hydroxychloroquine].
001104 (2013) Eun Lee [Corée du Sud] ; Ju-Hee Seo ; Hyung Young Kim ; Jinho Yu ; Won-Kyoung Jhang ; Seong-Jong Park ; Ji-Won Kwon ; Byoung-Ju Kim ; Kyung-Hyun Do ; Young Ah Cho ; Sun-A Kim ; Se Jin Jang ; Soo-Jong HongToxic inhalational injury-associated interstitial lung disease in children.
001627 (2010) Markus Woischnik [Allemagne] ; Christiane Sparr ; Sun Ana Kern ; Tobias Thurm ; Andreas Hector ; Dominik Hartl ; Gerhard Liebisch ; Surafel Mulugeta ; Michael F. Beers ; Gerd Schmitz ; Matthias GrieseA non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.
001833 (2009) Kenia Rodrigues ; Fabricio S. Neves ; Karin B. L. Stoeterau ; Gláucio R. Werner Castro ; Luiz F. Nobre [Brésil] ; Adriana F. Zimmermann ; Ivânio A. PereiraPulmonary amyloidosis in Sjögren’s syndrome: a rare diagnosis for nodular lung lesions
001E10 (2005) Dennis M. Rosen ; David A. WaltzHydroxychloroquine and surfactant protein C deficiency.
001F12 (2004) R. Dinwiddie [Royaume-Uni]Treatment of interstitial lung disease in children.
003060 (1990) E. Kerem [Canada] ; L. Bentur [Canada] ; S. England [Canada] ; J. Reisman [Canada] ; H. O'Brodovich [Canada] ; A. C. Bryan [Canada] ; H. Levison [Canada]Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis
004030 (????) Ana Catarina Duarte ; Filipe Vinagre ; Jorge Soares ; Ana CordeiroAntifibrotics in interstitial lung disease related to connective tissue diseases - a paradigm shift in treatment and outcome.
000C05 (2018) Matthew T. Koroscil [États-Unis] ; Craig A. Rohan ; Michael J. Morris ; Joshua N. ScottWong-Type Dermatomyositis Complicated by Interstitial Lung Disease.
000C10 (2018) Andreu Fernández-Codina [Espagne] ; Kyle M. Walker [Canada] ; Janet E. Pope [Canada]Treatment Algorithms for Systemic Sclerosis According to Experts.
000C40 (2018) Cécile Rotenberg [France] ; Valérie Besnard [France] ; Pierre-Yves Brillet [France] ; Stéphane Giraudier [France] ; Hilario Nunes [France] ; Dominique Valeyre [France]Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.
000F10 (2015) Silvia Montella [Italie] ; Timothy J. Vece [États-Unis] ; Claire Langston [États-Unis] ; Paola Carrera [Italie] ; Lawrence M. Nogee [États-Unis] ; Aaron Hamvas [États-Unis] ; Angelo Manna [Italie] ; Mariarosaria Cervasio ; Mara Cervasio [Italie] ; Francesca Santamaria [Italie]A disorder of surfactant metabolism without identified genetic mutations.
000F54 (2015) Sarah Braun [Allemagne] ; Marion Ferner [Allemagne] ; Kai Kronfeld [Allemagne] ; Matthias Griese [Allemagne]Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases
001013 (2014) J. Winter [Allemagne] ; S. Essmann [Allemagne] ; A. Kidszun [Allemagne] ; C. Aslanidis [Allemagne] ; M. Griese [Allemagne] ; K. Poplawska [Allemagne] ; M. Bartsch [Allemagne] ; G. Schmitz [Allemagne] ; E. Mildenberger [Allemagne]Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options.
001048 (2014) Michael Williamson [Royaume-Uni] ; Colin Wallis [Royaume-Uni]Ten‐year follow up of hydroxychloroquine treatment for ABCA3 deficiency
001050 (2014) Zeynep Ar Kan-Ayy Ld Z [Turquie] ; Sule Caglayan-Sozmen [Turquie] ; Sakine Is K [Turquie] ; Robin Deterding ; Megan K. Dishop ; Remy Couderc [France] ; Ralph Epaud [France] ; Malek Louha [France] ; Nevin Uzuner [Turquie]Survival of an infant with homozygous surfactant protein C (SFTPC) mutation
001059 (2014) Avraham Avital [Israël] ; Avigdor Hevroni [Israël] ; Simon Godfrey [Israël] ; Shlomo Cohen [Israël] ; Channa Maayan [Israël] ; Samir Nusair [Israël] ; Lawrence M. Nogee [États-Unis] ; Chaim Springer [Israël]Natural history of five children with surfactant protein C mutations and interstitial lung disease
001110 (2013) Karina Vilá-Rivera ; Esther Jiménez-Encarnaci N [Porto Rico] ; Salvador ViláPulmonary hemorrhage in a patient initially presenting with discoid lupus.
001160 (2013) Holger Meinicke [Allemagne] ; Andrea Heinzmann [Allemagne] ; Julia Geiger [Allemagne] ; Reinhard Berner [Allemagne] ; Markus Hufnagel [Allemagne]Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12‐year‐old girl
001205 (2013) Hiroshi Kitazawa [Japon] ; Kunihiko Moriya [Japon] ; Hidetaka Niizuma [Japon] ; Kengo Kawano [Japon] ; Yuka Saito-Nanjo [Japon] ; Toru Uchiyama [Japon] ; Takeshi Rikiishi [Japon] ; Yoji Sasahara [Japon] ; Osamu Sakamoto [Japon] ; Yasuhiro Setoguchi [Japon] ; Shigeo Kure [Japon]Interstitial lung disease in two brothers with novel compound heterozygous ABCA 3 mutations
001305 (2012) A. Aceti [Italie] ; R. Sciutti ; P R Bracci ; L. Bertelli ; F. Melchionda ; S. CazzatoIdiopathic pulmonary haemosiderosis in a child with Down's syndrome: case report and review of the literature.
001309 (2012) Don Hayes ; Eric A. Lloyd ; Jill A. Fitch ; Andrew BushABCA3 transporter deficiency.
001472 (2011) Jozélio Freire De Carvalho [Brésil] ; Licia Maria Henrique Da Mota ; Eloisa BonfaFatal rhabdomyolysis in systemic lupus erythematosus.
001616 (2010) María Del Rosario García-Luzardo ; Antonio José Aguilar-Fernández ; Gonzalo Cabrera-Roca[Idiopathic pulmonary haemosiderosis in childhood: a good response to systemic steroids, inhaled hydroxychloroquine and budesonide].
001619 (2010) Srinivas Rajagopala [Inde] ; Navneet Singh ; Kirti Gupta ; Dheeraj GuptaPulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature.
001E11 (2005) Hyo-Bin Kim [Corée du Sud] ; So-Yeon Lee ; Ja-Hyung Kim ; Ju-Young Jang ; Jooryung Huh ; Seong-Jong Park ; Soo-Jong HongFamilial interstitial lung disease in two young Korean sisters.
001E36 (2005) Haneen Adel Al-Raqum [Koweït] ; Sukhbir Singh Uppal [Koweït] ; Moudi Al-Mutairy [Koweït] ; Rakesh Kumari [Koweït]Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti
002433 (2000) A. Barbato [Italie] ; C. PanizzoloChronic interstitial lung disease in children.
002534 (2000) Doug Hacking ; Rosalind Smyth ; Nigel Shaw ; George Kokia ; Helen Carty ; David HeafIdiopathic pulmonary fibrosis in infants: good prognosis with conservative management
002712 (1999) M. M. Saeed [États-Unis] ; M. S. Woo [États-Unis] ; E. F. Maclaughlin [États-Unis] ; M. F. Margetis [États-Unis] ; T. G. Keens [États-Unis]Prognosis in pediatric idiopathic pulmonary hemosiderosis
002716 (1998) M. Marvisi[Osteoarticular sarcoidosis].
002717 (1998) N G Singer [États-Unis] ; W J MccuneUpdate on immunosuppressive therapy.
002848 (1998) A. Schnabel [Allemagne] ; M. Reuter [Allemagne] ; W. L. Gross [Allemagne]Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases
002853 (1997) M Z Norzila ; B H Azizi ; C T Deng ; A. ZulfiqarInterstitial lung disease in children--a report of four cases.
002854 (1997) B C HilmanDiagnosis and treatment of ILD.
002D12 (1993) M. Neurath ; A. Benzing ; P. Knolle ; H. Grundmann ; W. Dippold ; K H Meyer Zum Büschenfelde[Acute respiratory failure in tropical malaria during pregnancy. Successful treatment using extracorporeal CO2 elimination].
003362 (1986) M. Csuka ; G F Carrera ; D J MccartyTreatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.
003426 (1986) Carin E. Dugowson ; Bruce C. GillilandManagement of rheumatoid arthritis
000137 (2020) Xin Lyu [République populaire de Chine] ; Lizhong Zeng [République populaire de Chine] ; Hua Zhang [République populaire de Chine] ; Yue Ke [République populaire de Chine] ; Xuan Liu [République populaire de Chine] ; Nannan Zhao [République populaire de Chine] ; Jingyan Yuan [République populaire de Chine] ; Guoan Chen [République populaire de Chine] ; Shuanying Yang [République populaire de Chine]Hydroxychloroquine suppresses lung tumorigenesis via inducing FoxO3a nuclear translocation through STAT3 inactivation.
000262 (2019) J. Liu [République populaire de Chine] ; J H Chen [République populaire de Chine] ; Y Q Wang [République populaire de Chine] ; G M Nong [République populaire de Chine] ; Y J Zheng [République populaire de Chine] ; C L Hao [République populaire de Chine][Genetic variants in the surfactant protein C gene 218 site are associated with pediatric interstitial lung disease: seven cases study].
000863 (2019) Priyankar Pal [Inde] ; Hriday De [Inde] ; Prabhas Prasun Giri [Inde] ; Nupur Ganguly [Inde] ; Alolika Mandal [Inde]Early Initiation of Steroid-sparing Drugs in Idiopathic Pulmonary Hemosiderosis.
000935 (2019) Elizabeth C. Wight ; Misbah Baqir [États-Unis] ; Jay H. Ryu [États-Unis]Constrictive Bronchiolitis in Patients With Primary Sjögren Syndrome.
000B45 (2019) Georgios Mitsiakos [Grèce] ; Christos Tsakalidis [Grèce] ; Paraskevi Karagianni [Grèce] ; Dimitra Gialamprinou [Grèce] ; Ilias Chatziioannidis [Grèce] ; Ioannis Papoulidis [Grèce] ; Ioannis Tsanakas [Grèce] ; Vasiliki Soubasi [Grèce]A New ABCA3 Gene Mutation c.3445G>A (p.Asp1149Asn) as a Causative Agent of Newborn Lethal Respiratory Distress Syndrome
000C17 (2018) Oded Breuer [Australie] ; André Schultz [Australie]Side effects of medications used to treat childhood interstitial lung disease.
000C38 (2018) Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour]Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.
000C85 (2017) M. Aymonier [France] ; S. Abed [France] ; T. Boyé [France] ; H. Barazzutti [France] ; B. Fournier [France] ; J-J Morand [France][Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases].
000C86 (2017) J F Yu [République populaire de Chine] ; Y B Jin [République populaire de Chine] ; J. He [République populaire de Chine] ; Y. An [République populaire de Chine] ; Z G Li [République populaire de Chine][Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
000C93 (2017) Xuyao Zhang [République populaire de Chine] ; Jiajun Fan [République populaire de Chine] ; Shaofei Wang [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Yichen Wang [République populaire de Chine] ; Song Li [République populaire de Chine] ; Jingyun Luan [République populaire de Chine] ; Ziyu Wang [République populaire de Chine] ; Ping Song [République populaire de Chine] ; Qicheng Chen [République populaire de Chine] ; Wenzhi Tian [République populaire de Chine] ; Dianwen Ju [République populaire de Chine]Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer.
000C97 (2017) Howard L. Kaufman [États-Unis]Rational Combination Immunotherapy: Understand the Biology.
000D00 (2017) J. Demarchi [Argentine] ; S. Papasidero [Argentine] ; M A Medina [Argentine] ; D. Klajn [Argentine] ; R. Chaparro Del Moral [Argentine] ; O. Rillo [Argentine] ; V. Martiré [Argentine] ; G. Crespo [Argentine] ; A. Secco [Argentine] ; A. Catalan Pellet [Argentine] ; C. Amitrano [Argentine] ; C. Crow [Argentine] ; C. Asnal [Argentine] ; P. Pucci [Argentine] ; F. Caeiro [Argentine] ; N. Benzanquen [Argentine] ; J P Pirola [Argentine] ; M. Mayer [Argentine] ; F. Zazzetti [Argentine] ; S. Velez [Argentine] ; J. Barreira [Argentine] ; N. Tamborenea [Argentine] ; L. Santiago [Argentine] ; L. Raiti [Argentine]Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
000D01 (2017) Xiao Liu [République populaire de Chine] ; Hao Li [République populaire de Chine] ; Yunhong Yin [République populaire de Chine] ; Dedong Ma [République populaire de Chine] ; Yiqing Qu [République populaire de Chine]Primary Sjögren's syndrome with diffuse cystic lung changes developed systemic lupus erythematosus: a case report and literature review.
000D16 (2017) Otto Hartman [Finlande] ; Petri T. Kovanen [Finlande] ; Jukka Lehtonen [Finlande] ; Kari K. Eklund [Finlande] ; Juha Sinisalo [Finlande]Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial.
000D18 (2017) Elodie Nattes [France] ; Stephanie Lejeune [France] ; Ania Carsin [France] ; Raphael Borie [France] ; Isabelle Gibertini [France] ; Juan Balinotti [Argentine] ; Nadia Nathan [France] ; Sylvain Marchand-Adam [France] ; Caroline Thumerelle [France] ; Brigitte Fauroux [France] ; Emmanuelle Bosdure [France] ; Veronique Houdouin [France] ; Celine Delestrain [France] ; Malek Louha [France] ; Remy Couderc [France] ; Alix De Becdelievre [France] ; Pascale Fanen [France] ; Benoit Funalot [France] ; Bruno Crestani [France] ; Antoine Deschildre [France] ; Jean-Christophe Dubus [France] ; Ralph Epaud [France]Heterogeneity of lung disease associated with NK2 homeobox 1 mutations.
000E74 (2015) Loh-Shan B. Leung [États-Unis] ; Joel W. Neal [États-Unis] ; Heather A. Wakelee [États-Unis] ; Lecia V. Sequist [États-Unis] ; Michael F. Marmor [États-Unis]Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
000E88 (2015) Andrew Bush [Royaume-Uni] ; Steve Cunningham [Royaume-Uni] ; Jacques De Blic [France] ; Angelo Barbato [Italie] ; Annick Clement [France] ; Ralph Epaud [France] ; Meike Hengst [Allemagne] ; Nural Kiper [Turquie] ; Andrew G. Nicholson [Royaume-Uni] ; Martin Wetzke [Allemagne] ; Deborah Snijders [Italie] ; Nicolaus Schwerk [Allemagne] ; Matthias Griese [Allemagne]European protocols for the diagnosis and initial treatment of interstitial lung disease in children.
000E94 (2015) Shan Li ; Xin Yu Song ; Yu Yue Zhao ; Kai Xu ; Ya Lan Bi ; Hui Huang ; Zuo Jun XuClinical Analysis of Pulmonary Nocardiosis in Patients With Autoimmune Disease.
000E96 (2015) Ana Freitas [Portugal] ; Virgílio Senra [Portugal] ; Ant Nio Marinho [Portugal] ; Margarida Guedes [Portugal]Chronic alveolar haemorrhage in a paediatric patient: a diagnostic and treatment challenge.
000F04 (2015) Ralph Yachoui [États-Unis] ; Rahul Sehgal [États-Unis] ; Barkha Amlani [États-Unis] ; Jerry W. Goldberg [États-Unis]Antiphospholipid antibodies-associated diffuse alveolar hemorrhage.
000F05 (2015) Kwan-Hwa Chi [Taïwan] ; Hui-Ling Ko [Taïwan] ; Kai-Lin Yang [Taïwan] ; Cheng-Yen Lee [Taïwan] ; Mau-Shin Chi [Taïwan] ; Shang-Jyh Kao [Taïwan]Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort.
000F06 (2015) Bernice Lo [États-Unis] ; Kejian Zhang [États-Unis] ; Wei Lu [États-Unis] ; Lixin Zheng [États-Unis] ; Qian Zhang [États-Unis] ; Chrysi Kanellopoulou [États-Unis] ; Yu Zhang [États-Unis] ; Zhiduo Liu [États-Unis] ; Jill M. Fritz [États-Unis] ; Rebecca Marsh [États-Unis] ; Ammar Husami [États-Unis] ; Diane Kissell [États-Unis] ; Shannon Nortman [États-Unis] ; Vijaya Chaturvedi [États-Unis] ; Hilary Haines [États-Unis] ; Lisa R. Young [États-Unis] ; Jun Mo [États-Unis] ; Alexandra H. Filipovich [États-Unis] ; Jack J. Bleesing [États-Unis] ; Peter Mustillo [États-Unis] ; Michael Stephens [États-Unis] ; Cesar M. Rueda [États-Unis] ; Claire A. Chougnet [États-Unis] ; Kasper Hoebe [États-Unis] ; Joshua Mcelwee [États-Unis] ; Jason D. Hughes [États-Unis] ; Elif Karakoc-Aydiner [Turquie] ; Helen F. Matthews [États-Unis] ; Susan Price [États-Unis] ; Helen C. Su [États-Unis] ; V Koneti Rao [États-Unis] ; Michael J. Lenardo [États-Unis] ; Michael B. Jordan [États-Unis]AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
000F73 (2015) Neil J. Hime [Australie] ; Yvonne Zurynski [Australie] ; Dominic Fitzgerald [Australie] ; Hiran Selvadurai [Australie] ; Amy Phu [Australie] ; Marie Deverell [Australie] ; Elizabeth J. Elliott [Australie] ; Adam Jaffe [Australie]Childhood interstitial lung disease: A systematic review
001005 (2014) Sonia Hammami [Tunisie] ; Fethia Bdioui [Tunisie] ; Afef Ouaz [Tunisie] ; Hichem Loghmari [Tunisie] ; Sylvia Mahjoub [Tunisie] ; Hamouda Saffar [Tunisie]Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus.
001107 (2013) N. Hepping [Allemagne] ; M. Griese ; P. Lohse ; W. Garbe ; L. LangeSuccessful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine.
001111 (2013) V L S. Marques [Brésil] ; R C Gomes ; G R Viola ; M M Maia ; G S Durigon ; N E Aikawa ; C. Artur SilvaPulmonary cryptococcosis in childhood systemic lupus erythematosus and Sjögren syndrome overlap: a rare opportunistic infection.
001131 (2013) Eya Cherif [Tunisie] ; Lamia Ben Hassine [Tunisie] ; Ines Kechaou [Tunisie] ; Narjess Khalfallah [Tunisie]Phalangeal lytic lesion: do not forget osseous sarcoidosis
001295 (2012) Kyle M. Walker [Irlande (pays)] ; Janet PopeTreatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
001310 (2012) Sarah B. Goldberg [États-Unis] ; Jeffrey G. Supko ; Joel W. Neal ; Alona Muzikansky ; Subba Digumarthy ; Panos Fidias ; Jennifer S. Temel ; Rebecca S. Heist ; Alice T. Shaw ; Patricia O. Mccarthy ; Thomas J. Lynch ; Sreenath Sharma ; Jeffrey E. Settleman ; Lecia V. SequistA phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.
001474 (2011) Shivakumar Narayanan [États-Unis] ; Chandralekha Banerjee ; Peter A. HoltCryptococcal immune reconstitution syndrome during steroid withdrawal treated with hydroxychloroquine.
001522 (2011) C. L. Teh [Malaisie] ; J. S. Wong [Malaisie] ; H. H. Soo [Malaisie]Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital
001622 (2010) Jagdish Prasad Goyal [Inde] ; Vijay B Shah ; Nagender KumarDiffuse pulmonary hemorrhage as presenting syndrome of HIV disease.
001648 (2010) Guillaume Thouvenin [France] ; Rola Abou Taam [France] ; Florence Flamein [France] ; Loïc Guillot [France] ; Muriel Le Bourgeois [France] ; Philippe Reix [France] ; Mickael Fayon [France] ; François Counil [France] ; Ulrika Depontbriand [France] ; Delphine Feldmann [France] ; Hubert Ducou-Le Pointe [France] ; Jacques De Blic [France] ; Annick Clement [France] ; Ralph Epaud [France]Characteristics of disorders associated with genetic mutations of surfactant protein C
001A55 (2007) S K Kabra [Inde] ; Sumit Bhargava ; Rakesh Lodha ; A. Satyavani ; M. WaliaIdiopathic pulmonary hemosiderosis: clinical profile and follow up of 26 children.
001C13 (2006) S. Paramothayan ; T J Lasserson ; E H WaltersImmunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
002037 (2003) Piera Fazzi [Italie]Pharmacotherapeutic management of pulmonary sarcoidosis.
002159 (2002) Ana Climent-Albaladejo [Espagne] ; Encarnacion Saiz-Cuenca ; Juan Rosique-Roman ; Julian Caballero-Rodriguez ; Jose Galvez-MunozDermatomyositis sine myositis and antisynthetase syndrome.
002252 (2002) Anne-Marie Canakis [Canada] ; Ernest Cutz [Canada] ; David Manson [Canada] ; Hugh O'Brodovich [Canada]Pulmonary interstitial glycogenosis: A new variant of neonatal interstitial lung disease
002431 (2000) O P Sharma [États-Unis]Hypercalcemia in granulomatous disorders: a clinical review.
002434 (2000) R. Dinwiddie [Royaume-Uni]Case 3: Assessment: systemic illness and the chest.
002718 (1998) A A Ali ; M P Iqbal ; M A Hussain ; N. Mehboobali ; J A Beg ; M H RahbarMethotrexate in rheumatoid arthritis: a 2 year experience at a university hospital in Pakistan.
002850 (1998) O. P. Sharma [États-Unis]Effectiveness of Chloroquine and hydroxychloroquine in treating selected patients with Sarcoidosis with neurological involvement
002852 (1997) S. Brenner [Israël] ; H. Golan ; A. Gat ; A. Bialy-GolanParaneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung.
002942 (1997) Napa Balasubramanyan [États-Unis] ; Anne Murphy [Irlande (pays)] ; Joe O'Sullivan [Irlande (pays)] ; Edward J. O'Connell [États-Unis]Familial interstitial lung disease in children: Response to chloroquine treatment in one sibling with desquamative interstitial pneumonitis
002B53 (1995) Ra Yood [États-Unis] ; Dm Steigman ; Lr GillLymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus
003101 (1989) L V Ozerova ; I E Stepanian ; V V Romanov ; T A Kireeva[Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].
003102 (1989) S K Gupta [Inde]Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.
003103 (1989) L. Rockhold ; V. HarisdangkulRheumatoid arthritis occurring with sickle cell anemia--treatment dilemma.
003547 (1984) Z I Kostina[Complex treatment of patients with sarcoidosis of the respiratory organs].

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021